[
  {
    "ts": "2025-12-15T15:00:00+00:00",
    "headline": "Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks",
    "summary": "ST. LOUIS, December 15, 2025--Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures. The financing is intended to accelerate Cofactor’s nationwide expansion and broaden patient access to its immunotherapy-response diagnostics.",
    "url": "https://finance.yahoo.com/news/cofactor-genomics-announces-strategic-investment-150000896.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "698180b9-4d10-3892-acfa-e5f7af920d1e",
      "content": {
        "id": "698180b9-4d10-3892-acfa-e5f7af920d1e",
        "contentType": "STORY",
        "title": "Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks",
        "description": "",
        "summary": "ST. LOUIS, December 15, 2025--Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures. The financing is intended to accelerate Cofactor’s nationwide expansion and broaden patient access to its immunotherapy-response diagnostics.",
        "pubDate": "2025-12-15T15:00:00Z",
        "displayTime": "2025-12-15T15:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/b0654cf849c25a9e9a80d426c4b71dee",
          "originalWidth": 480,
          "originalHeight": 240,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zR9XIHdNctciaPSj6n_d3Q--~B/aD0yNDA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/b0654cf849c25a9e9a80d426c4b71dee.cf.webp",
              "width": 480,
              "height": 240,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SYtzh5D.SR60POa34eCWDA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/b0654cf849c25a9e9a80d426c4b71dee.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cofactor-genomics-announces-strategic-investment-150000896.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cofactor-genomics-announces-strategic-investment-150000896.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]